Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombolytic (t-PA) Treatment”

68 trials

Showing 20 of 68 results

Post-approval studies (Phase 4)Active Not RecruitingNCT03581877
What this trial is testing

Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE

Who this might be right for
Pulmonary EmbolismPulmonary HypertensionThromboembolism+1 more
Northwell Health 31
Not applicableNot Yet RecruitingNCT07519889
What this trial is testing

Observational Study to Assess the Safety of rhTNK-tPA (Mingfule®) vs. Rt-PA (Actilyse®) in Treating Acute Ischemic Stroke

Who this might be right for
Acute Ischemic StrokerhTNK-tPA
CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. 4,500
Not applicableStudy completedNCT06812000
What this trial is testing

Post-stroke Seizure and Epilepsy Following Thrombolytic Therapy

Who this might be right for
Post-stroke SeizurePost-stroke EpilepsyThrombolytic (t-PA) Treatment
Mazandaran University of Medical Sciences 199
Testing effectiveness (Phase 2)UnknownNCT01253512
What this trial is testing

Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA)

Who this might be right for
Acute Ischemic Stroke
Thrombotech Ltd. 22
Large-scale testing (Phase 3)Looking for participantsNCT07201688
What this trial is testing

Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.

Who this might be right for
Acute Ischemic Stroke
CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. 890
Early research (Phase 1)Study completedNCT00055159
What this trial is testing

Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins

Who this might be right for
Thrombosis
National Institutes of Health Clinical Center (CC) 50
Not applicableUnknownNCT02974283
What this trial is testing

Protective Effects of Normobaric Hyperoxia on Blood Brain Barrier in Patients With Acute Ischemic Stroke

Who this might be right for
Stroke, Acute
Capital Medical University 40
Early research (Phase 1)Looking for participantsNCT06814964
What this trial is testing

RhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage

Who this might be right for
Intraventricular Hemorrhage
Beijing Tiantan Hospital 18
Large-scale testing (Phase 3)UnknownNCT00336596
What this trial is testing

Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion

Who this might be right for
Intracranial EmbolismThrombosis
University of Zurich 400
Testing effectiveness (Phase 2)Study completedNCT01977456
What this trial is testing

Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)

Who this might be right for
StrokeBrain Infarction
Arthur Pancioli 27
Testing effectiveness (Phase 2)Study completedNCT02388061
What this trial is testing

Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke

Who this might be right for
Ischemic Stroke
Neuroscience Trials Australia 202
Testing effectiveness (Phase 2)Ended earlyNCT01492725
What this trial is testing

Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial

Who this might be right for
Ischemic Stroke
Neuroscience Trials Australia 70
Large-scale testing (Phase 3)Study completedNCT04640194
What this trial is testing

Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19

Who this might be right for
Acute Respiratory Distress Syndrome
Boehringer Ingelheim 104
Not applicableStudy completedNCT01614080
What this trial is testing

Outcome of Patients Treated by iv Rt-PA for Cerebral Ischaemia According to the Ratio Sc-tPA/Tc-tPA

Who this might be right for
Stroke, AcuteDrug Toxicity
University Hospital, Lille 700
Testing effectiveness (Phase 2)WithdrawnNCT02150785
What this trial is testing

Asia Africa Streptokinase Trial

Who this might be right for
Ischemic Stroke
University of Alberta
Not applicableStudy completedNCT03048292
What this trial is testing

New York City Mobile Interventional Stroke Team

Who this might be right for
Acute Stroke
Icahn School of Medicine at Mount Sinai 191
Testing effectiveness (Phase 2)UnknownNCT05188417
What this trial is testing

A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
GrandPharma (China) Co., Ltd. 266
Post-approval studies (Phase 4)UnknownNCT02029456
What this trial is testing

Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism

Who this might be right for
Pulmonary Embolism
Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital 30
Not applicableStudy completedNCT02358772
What this trial is testing

Comparison of Pre-hospital and In-hospital Iv-tPA Stroke Treatment

Who this might be right for
Ischemic Stroke
Charite University, Berlin, Germany 658
Large-scale testing (Phase 3)Study completedNCT00860366
What this trial is testing

Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Angel Chamorro, MD 421
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation